ARCA biopharma Inc.

NASDAQ: ABIO · Real-Time Price · USD
28.80
26.30 (1052.00%)
At close: Aug 30, 2024, 10:00 PM

ARCA biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
111K 114K 91K
Gross Profit
-111K -114K -91K
Operating Income
-7.3M -10.6M -19.34M
Interest Income
1.96M 675K 13K
Pretax Income
-5.34M -9.93M -19.32M
Net Income
-5.34M -9.93M -19.32M
Selling & General & Admin
6.28M 5.85M 5.5M
Research & Development
1.01M 4.75M 13.83M
Other Expenses
n/a -5K n/a
Operating Expenses
7.3M 10.6M 19.34M
Interest Expense
n/a 675K n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
7.3M 10.6M 19.34M
Income Tax Expense
n/a -670K -91K
Shares Outstanding (Basic)
14.42M 14.41M 13.9M
Shares Outstanding (Diluted)
14.42M 14.41M 13.9M
EPS (Basic)
-0.37 -0.69 -1.39
EPS (Diluted)
-0.37 -0.69 -1.39
EBITDA
-7.3M -10.48M -19.24M
EBIT
n/a -9.25M -19.34M
Depreciation & Amortization
111K 114K 91K